Clinical Trials Browser

Observational × Monoclonal Gammopathy of Undetermined Significance × 30 days × Clear all

NCT02726750 2026-04-16

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT06383143 2026-04-16

ProDigALIty

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance

NCT05136807 2026-04-15

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT05361694 2026-04-09

TRANSFORMM

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT01408225 2026-03-23

B-SCR-MM

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

NCT05969821 2026-03-23

CHIS

Not yet recruiting

LymphoidMyeloidOther hematologic neoplasm

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases